Please Wait...

SigTrace

End-to-End Signal Management Tool

SigTrace is a consolidated, end-to-end signal management tool that manages signal detection validation, analysis, prioritization, assessment, recommendation for action and exchange of information. SigTrace integrates directly with the safety database and has a built-in reporting engine to help manage the entire signal management process.

Benefits of SigTrace include:

  • Consolidates all parts of the signal management process (signal evaluation, validation, analysis, prioritization, assessment and recommendation for action) into one tool, providing a clear overview of the entire process
  • Integrates directly with the safety database, providing efficiencies (eliminating manual extraction) and ensures that data used for the signal management process originates from a validated source and is not prone to corruption
  • Semi-automated features for detection, form validation checks, reports and notifications including:
    • Signal validation – workflow to decide if the safety observation is a potential signal or not. Based on this, a signal is either validated or not validated
    • Signal analysis and prioritization – workflow to analyze and prioritize signals
    • Signal assessment – workflow to further evaluate validated signals to establish the causal relationship (rejected or confirmed signal) or to identify the need for additional data collection (undetermined signal). A customized report can also be generated to assess these signals.
    • Recommendations for action and communication – for confirmed signals
  • Generates comprehensive reports to ensure the entire process is managed appropriately – If findings are discovered, SigTrace has the data to identify the specific break in process.
  • Replaces the traditional mix of disparate processes, environments, databases and tools associated with signal management
  • All data is stored within SigTrace, eliminating the need for separate database or file storage repositories.

Download our info sheet

ADDITIONAL RESOURCES

LitTrace and PVTrace

Download Info Sheet

Meet the Bioclinica Safety and Regulatory Team: Sukrit Singh, Engagement Manager

Read Blog

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

Handy guide for the pharmacovigilance folks! https://t.co/tOyQWkiNhW
bioclinica (Yesterday)
#ClinicalResearch sites, REJOICE @bioclinica SMART Submit 4 cloud rsch image mgmt /subm is here! @OutsourcPharmahttp://ow.ly/odCh30grhnY
bioclinica (Yesterday)
What's next from Bioclinica? Hear if first during #PCTrials Europe next week in Amsterdam! https://t.co/ICngaxA9mg https://t.co/SXxPj3NpD2
bioclinica (2 days ago)
Join Bioclinica's Justin Hunt on Nov. 28 in a live webinar! Find out how to overcome common hurdles in CTMS impleme… https://t.co/wHfWHtI7sj
bioclinica (3 days ago)
Another CRO seeing big gains in the sites payments process! Access the Case Study here https://t.co/jsCxhmKcLo https://t.co/LpIKEtBKtE
bioclinica (3 days ago)
Great advice from our Dir. Cardiovascular Imaging on quality imaging acquisitions & assessments in clin trials. https://t.co/OVH7pZ3SL0
bioclinica (3 days ago)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen
Congressman Meehan and Bioclinica CEO John Hubbard at recent visit to Bioclinica's Audubon offices